Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial).

[1]  G. Parati,et al.  Lung ultrasound and transthoracic impedance for noninvasive evaluation of pulmonary congestion in heart failure , 2016, Journal of cardiovascular medicine.

[2]  Y. Rozenman,et al.  Derivation of baseline lung impedance in chronic heart failure patients: use for monitoring pulmonary congestion and predicting admissions for decompensation , 2015, Journal of Clinical Monitoring and Computing.

[3]  H. Olschewski,et al.  Characterization of patients with borderline pulmonary arterial pressure. , 2014, Chest.

[4]  D. Gutfinger,et al.  Thoracic impedance measures tissue characteristics in the vicinity of the electrodes, not intervening lung water: implications for heart failure monitoring , 2014, Journal of Clinical Monitoring and Computing.

[5]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[6]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[7]  N. Goldenberg,et al.  From the Journal archives: Understanding the mechanism(s) regulating hypoxic pulmonary vasoconstriction: how an early study has led to novel translational approaches , 2014, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[8]  Bruce D. Johnson,et al.  A possible role for systemic hypoxia in the reactive component of pulmonary hypertension in heart failure. , 2013, Journal of cardiac failure.

[9]  Y. Rozenman,et al.  Usefulness of lung impedance-guided pre-emptive therapy to prevent pulmonary edema during ST-elevation myocardial infarction and to improve long-term outcomes. , 2012, The American journal of cardiology.

[10]  S. Manzano-Fernández,et al.  Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. , 2012, American heart journal.

[11]  G. Parati,et al.  Transthoracic impedance accurately estimates pulmonary wedge pressure in patients with decompensated chronic heart failure. , 2012, Congestive heart failure.

[12]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[13]  M. Borggrefe,et al.  Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure , 2011, Circulation.

[14]  Y. Rozenman,et al.  A novel radiological score to assess lung fluid content during evolving acute heart failure in the course of acute myocardial infarction , 2011, Acute cardiac care.

[15]  P. Ponikowski,et al.  Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. , 2011, European heart journal.

[16]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[17]  P. Ponikowski,et al.  Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine , 2010, European journal of heart failure.

[18]  T. Dobbins,et al.  The relationship between pulmonary artery and pulmonary capillary wedge pressure for the diagnosis of pulmonary vascular disease. , 2010, Heart, lung & circulation.

[19]  M. Mosseri,et al.  Prediction of cardiogenic pulmonary edema onset by monitoring right lung impedance , 2006, Intensive Care Medicine.

[20]  Milton Packer,et al.  Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. , 2006, Journal of the American College of Cardiology.

[21]  Morris Mosseri,et al.  Internal thoracic impedance monitoring: a novel method for the preclinical detection of acute heart failure. , 2006, Cardiovascular revascularization medicine : including molecular interventions.